“Combination of Axitinib and Dasatinib for Anti-Cancer Activities in Two Prostate Cancer Cell Lines”. 2015. Bangladesh Journal of Pharmacology 11 (1): 130-37. https://doi.org/10.3329/bjp.v11i1.24149.